Takashi Kadowaki Selected Research

Takashi Kadowaki Research Topics

Disease

121	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2002
113	Insulin Resistance 11/2021 - 01/2002
67	Obesity 01/2022 - 01/2002
37	Atherosclerosis 01/2022 - 07/2002
37	Body Weight (Weight, Body) 01/2022 - 02/2002
26	Glucose Intolerance 01/2022 - 07/2002
26	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 10/2003
24	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2005
20	Hypoglycemia (Reactive Hypoglycemia) 04/2021 - 12/2004
20	Diabetes Mellitus 06/2020 - 01/2002
18	Hyperglycemia 01/2020 - 01/2002
17	Neoplasms (Cancer) 01/2022 - 01/2003
15	Inflammation (Inflammations) 01/2022 - 08/2002
15	Hypertension (High Blood Pressure) 12/2021 - 11/2002
13	Hypertrophy 06/2015 - 01/2002
9	Carcinogenesis 01/2017 - 02/2003
8	Diabetes Complications 12/2021 - 02/2004
7	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 04/2005
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2021 - 01/2010
6	Stroke (Strokes) 01/2021 - 08/2004
6	Adult-onset citrullinemia type 2 12/2019 - 08/2007
5	Hypoadiponectinemia 09/2022 - 09/2002
5	Chronic Renal Insufficiency 01/2022 - 06/2018
5	Myocardial Infarction 12/2021 - 12/2017
5	Ischemia 12/2021 - 06/2003
5	Albuminuria 08/2021 - 10/2007
5	Fibrosis (Cirrhosis) 02/2020 - 03/2005
5	Weight Gain 06/2019 - 02/2010
5	Hypercholesterolemia 01/2016 - 07/2004
5	Fatty Liver 07/2012 - 05/2004
4	Weight Loss (Weight Reduction) 01/2019 - 07/2004
4	Hyperinsulinism (Hyperinsulinemia) 11/2018 - 06/2004
4	Metabolic Diseases (Metabolic Disease) 11/2017 - 04/2005
3	Drug-Related Side Effects and Adverse Reactions 10/2022 - 11/2013

Drug/Important Bio-Agent (IBA)

71	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2002
63	Insulin (Novolin)FDA Link 12/2021 - 01/2002
62	AdiponectinIBA 09/2022 - 02/2002
30	PPAR gammaIBA 02/2010 - 01/2002
24	Triglycerides (Triacylglycerol)IBA 12/2021 - 02/2005
22	Hypoglycemic Agents (Hypoglycemics)IBA 11/2020 - 12/2003
18	LipidsIBA 01/2021 - 01/2003
17	Blood Glucose (Blood Sugar)IBA 12/2021 - 04/2003
15	Proteins (Proteins, Gene)FDA Link 02/2020 - 08/2002
14	Insulin ReceptorIBA 11/2021 - 06/2003
14	CholesterolIBA 01/2020 - 07/2004
13	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2022 - 11/2013
13	Insulin Receptor Substrate ProteinsIBA 12/2018 - 11/2002
12	AdipokinesIBA 09/2022 - 02/2004
12	Pharmaceutical PreparationsIBA 01/2021 - 02/2005
12	LigandsIBA 01/2016 - 03/2002
11	LeptinIBA 09/2022 - 09/2002
11	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 01/2003
11	Messenger RNA (mRNA)IBA 12/2018 - 12/2003
11	Adiponectin ReceptorsIBA 01/2017 - 12/2003
10	EnzymesIBA 12/2021 - 06/2004
10	Insulin Glargine (Lantus)FDA Link 03/2017 - 06/2009
10	Pioglitazone (Actos)FDA Link 11/2013 - 03/2002
9	SodiumIBA 01/2022 - 08/2005
8	Transcription Factors (Transcription Factor)IBA 01/2020 - 03/2003
8	Hemoglobins (Hemoglobin)IBA 04/2016 - 04/2007
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 09/2002
8	CytokinesIBA 12/2013 - 09/2002
7	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 12/2015
7	HDL CholesterolIBA 12/2021 - 05/2007
7	LDL CholesterolIBA 01/2021 - 11/2008
7	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 10/2011
7	Hormones (Hormone)IBA 09/2014 - 07/2002
7	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2011 - 07/2002
7	Rosiglitazone (Avandia)FDA Link 10/2009 - 07/2002
6	citrinIBA 12/2019 - 08/2007
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2015 - 04/2005
6	CalciumIBA 09/2014 - 12/2004
6	Antihypertensive Agents (Antihypertensives)IBA 05/2007 - 08/2005
5	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2003
5	Biological ProductsIBA 11/2017 - 02/2003
5	C-Reactive ProteinIBA 01/2016 - 08/2009
5	2,4-thiazolidinedione (thiazolidinedione)IBA 06/2011 - 03/2006
5	AMP-Activated Protein KinasesIBA 06/2011 - 03/2006
4	LinagliptinIBA 10/2022 - 01/2020
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2017
4	CanagliflozinIBA 01/2022 - 01/2017
4	empagliflozinIBA 01/2022 - 06/2014
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 07/2013
4	insulin degludecIBA 04/2021 - 09/2016
4	AdipoRonIBA 01/2021 - 11/2013
4	glimepiride (Amarel)FDA LinkGeneric 01/2021 - 12/2008
4	CarbohydratesIBA 12/2019 - 11/2012
4	Sterol Regulatory Element Binding Protein 1IBA 01/2019 - 06/2005
4	GlucokinaseIBA 12/2018 - 06/2004
4	Peptides (Polypeptides)IBA 10/2017 - 02/2002
4	C-PeptideIBA 01/2017 - 01/2010
4	Glycerolphosphate Dehydrogenase (Glycerol 3 Phosphate Dehydrogenase)IBA 09/2015 - 08/2007
4	oxidized low density lipoproteinIBA 07/2013 - 09/2006
4	Pyruvic Acid (Pyruvate)IBA 11/2012 - 08/2007
4	ThiazolidinedionesIBA 05/2011 - 04/2005
4	PPAR alphaIBA 12/2005 - 12/2003

Therapy/Procedure

39	Therapeutics 09/2022 - 08/2002
22	Glycemic Control 08/2021 - 04/2007
6	Drug Therapy (Chemotherapy) 01/2022 - 11/2008
4	Injections 01/2016 - 06/2010